WTA requires genetic sex testing for players in women's tennis

The WTA has announced that tennis players will be required to undergo a one-time genetic test for the SRY gene to participate in the women's tour. This new policy will come into effect on July 28, 2026, and players refusing to comply may face disciplinary action. The decision aims to establish a clear eligibility standard, following similar regulations introduced by World Athletics and World Boxing. Previous WTA rules permitted the inclusion of transgender women under specific testosterone level conditions. The WTA emphasized its commitment to confidentiality, dignity for all players, and the implementation of the policy with care.